Moreover, studies on patients with idiopathic pulmonary fibrosis with long-term hypoxia and accompanying comorbidities demonstrated that pirfenidone suppressed lung inflammation and fibrosis development by blocking the NLRP3 inflammasome (27). This evidence concerns the gene NLRP3 and idiopathic pulmonary fibrosis.